Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wall

Showing results (411-420 of 448) with videos related to

Pageof 45
Sort By:
BMJ Open|January 14, 2026
Trajectory, healthcare utilisation and recovery in 3590 individuals with long covid: a 4-year prospective cohort analysisJai Prashar, Toby Hillman, Emma C Wall, et al.
Lancet (London, England)|October 9, 2022
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessedMary Y Wu, Edward J Carr, Ruth Harvey, et al.
Communications Chemistry|February 5, 2026
Ionic liquid-coated gold core polymeric nanoparticles for selective neutrophil hitchhiking towards endometriosis treatmentPriyavrat Vashisth, Lauren T D Clerc, Duoyi Hu, et al.
Nature Biotechnology|March 4, 2022
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blockingAndrea R Shiakolas, Kevin J Kramer, Nicole V Johnson, et al.
Vaccine|March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeuticsGiulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Frontiers in Medical Technology|March 20, 2023
Assessment of a novel continuous cleaning device using metatranscriptomics in diverse hospital environmentsJustin R Wright, Truc T Ly, Karen B Cromwell, et al.
Lancet (London, England)|March 14, 2024
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaignMarianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, et al.
Cell Reports. Medicine|November 7, 2023
SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypesSteven C Wall, Naveenchandra Suryadevara, Changil Kim, et al.
Lancet (London, England)|July 1, 2021
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOCEmma C Wall, Mary Wu, Ruth Harvey, et al.
Lancet (London, England)|June 6, 2021
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccinationEmma C Wall, Mary Wu, Ruth Harvey, et al.
Pageof 45

Showing results (411-420 of 448) with videos related to

Sort By:
Pageof 45
BMJ Open|January 14, 2026
Trajectory, healthcare utilisation and recovery in 3590 individuals with long covid: a 4-year prospective cohort analysisJai Prashar, Toby Hillman, Emma C Wall, et al.
Lancet (London, England)|October 9, 2022
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessedMary Y Wu, Edward J Carr, Ruth Harvey, et al.
Communications Chemistry|February 5, 2026
Ionic liquid-coated gold core polymeric nanoparticles for selective neutrophil hitchhiking towards endometriosis treatmentPriyavrat Vashisth, Lauren T D Clerc, Duoyi Hu, et al.
Nature Biotechnology|March 4, 2022
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blockingAndrea R Shiakolas, Kevin J Kramer, Nicole V Johnson, et al.
Vaccine|March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeuticsGiulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Frontiers in Medical Technology|March 20, 2023
Assessment of a novel continuous cleaning device using metatranscriptomics in diverse hospital environmentsJustin R Wright, Truc T Ly, Karen B Cromwell, et al.
Lancet (London, England)|March 14, 2024
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaignMarianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, et al.
Cell Reports. Medicine|November 7, 2023
SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypesSteven C Wall, Naveenchandra Suryadevara, Changil Kim, et al.
Lancet (London, England)|July 1, 2021
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOCEmma C Wall, Mary Wu, Ruth Harvey, et al.
Lancet (London, England)|June 6, 2021
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccinationEmma C Wall, Mary Wu, Ruth Harvey, et al.
Pageof 45